Loading...

Follow Schaeffer's Research on Feedspot

Continue with Google
Continue with Facebook
or

Valid
<p>It's been a red-hot year for initial public offerings (IPOs). While big names <strong><a href="https://www.schaeffersresearch.com/content/news/2019/06/11/downgraded-beyond-meat-stock-set-for-worst-day-ever">Beyond Meat (BYND)</a></strong> and <strong><a href="https://www.schaeffersresearch.com/content/options/2019/06/19/uber-technologies-stock-targeted-for-bearish-options-trade">Uber Technologies (UBER)</a></strong> have stolen most of the limelight, online pet supplies retailer <strong>Chewy Inc (NYSE:CHWY)</strong> made its trading debut last Friday, June 14, opening at $36 -- well above its IPO price of $22.</p> <p>CHWY stock topped out at a record high of $41.34 on its first day of trading, before tagging an all-time low of $32.67 the following session. The shares were last seen down 1.1% today at $34.51, but are still comfortably north of their IPO price. </p> <p> Meanwhile, Chewy's options began trading today, and initial volume is light on an absolute basis. Most recently, 599 calls have changed hands, compared to 573 puts. The July 30 put is most active, and it looks like new positions are being purchased here, while speculators may also be buying to open August 25 puts. If this is the case, <strong><a href="https://www.schaeffersresearch.com/education/options-strategies/bearish-options-strategies/long-put-options">put buyers</a></strong> expect CHWY to sell off over the next eight weeks.</p> <p>On the call side, the July 40 strike is most active. The bulk of the activity here has occurred on the bid side, suggesting the calls are being sold to open. In this scenario, speculators will be able to pocket the credit collected should CHWY stock stay south of the round $40 mark through July expiration. Risk for the <strong><a href="https://www.schaeffersresearch.com/education/options-strategies/bearish-options-strategies/short-call">call sellers</a></strong> is theoretically unlimited on a sharp move to the upside from the underlying equity.</p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p>The S&amp;P hit a <strong><a href="https://www.schaeffersresearch.com/content/ezines/2019/06/20/s-p-tags-new-high-in-fed-fueled-rally">new intraday high</a></strong> earlier today as investors digested dovish comments from the Fed. Three individual stocks making notable moves today are drugmakers&nbsp;<strong>Edesa Biotech Inc (NASDAQ:EDSA)</strong> and&nbsp;<strong>DiaMedica Therapeautics Inc (NASDAQ:DMAC)</strong>, as well as mobile payments processor <strong>Net Element Inc</strong> <strong>(NASDAQ:NETE).</strong> Here's a look at what's moving the shares of EDSA, DMAC, and NETE.&nbsp;</p> <h2>EDSA Stock Doubles on FDA Nod&nbsp;</h2> <p>Edesa Biotech gained approval from the Food and Drug Administration (FDA) to proceed with a mid-stage study of its EB01 therapy, used to treat patients with chronic allergic contact dermatitis. Edesa plans on enrolling its first patient in the upcoming quarter, and the shares have nearly doubled in response -- up 96.3% at $8.24, pacing for their best day ever.&nbsp;</p> <p>In earlier trading, the stock had more than tripled off last night's close, briefly topping the 320-day moving average -- a trendline the security has surged past several times in the past year, but hasn't closed atop since 2014. Earlier this week, the equity bottomed out at a record low of $3.59.</p> <h2><span style="font-size: 18px;">Study Success Stokes DMAC Stock's Red-Hot Rally</span></h2> <p>The shares of DMAC are are set for their fifth win in six days, after the biotech announced promising early stage trial data for its DM199 drug, used to treat chronic kidney disease. The firm said the drug had no serious side effects, and might be able to restore normal levels of a protein that may be linked to some kidney and heart conditions. The equity hit a six-month high of $5.93 earlier today, and is now trading up 31.2% at $5.01.&nbsp;</p> <p>DMAC's announcement has analysts taking notice, with Craig-Hallum lifting its target price to $11 from $9, while maintaining its "buy" rating. Analysts have been fairly bullish on the stock prior to today, though, with all three brokerages dishing out a "buy" or better rating, and a consensus 12-month target price of $8.67, which is a roughly 78% premium to current levels.&nbsp;</p> <p> </p> <h2>NETE Stock Pops on Crypto Buzz</h2> <p>Online payments concern Net Element just announced today that it would start accepting cryptocurrency payments on its cloud-based software, Aptito. The announcement, which follows the launch of <strong><a href="https://www.schaeffersresearch.com/content/options/2019/06/17/facebook-call-options-pop-ahead-of-cryptocurrency-reveal">Facebook's Libra cryptocurrency</a></strong>, has NETE stock up 10% at $4.40, eyeing its third straight win.&nbsp;</p> <p>Looking at the charts, NETE still has a ways to go. The stock recently bottomed out at eight-month lows, pressured by its 10- and 20-day moving averages. While the equity has broken out above these trendlines in today's bull gap, it's still 23% below its year-to-date breakeven mark. </p> <p>While some shorts took profits during NETE's recent slide to new lows, there are still 349,140 shares dedicated to these bearish bets. This represents a healthy 10.2% of the stock's available float, or 10.2 times the average daily pace of trading.</p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p>Biotech concerns<strong> Precipio Inc (NASDAQ:PRPO) </strong>and <strong>Aptinyx Inc (NASDAQ:APTX) </strong>scored new analyst ratings today, with the brokerage firms expecting big moves for the penny stocks. Both equities have struggled so far in 2019, but their new price targets suggest Wall Street is rolling the dice on a comeback.</p> <p>Alliance Global Partners launched coverage of PRPO stock with a "buy" rating and $6.30 price target -- more than double the equity's current price. The analysts said Precipio &ldquo;has staked out a unique position within hematological cancer diagnostics,&rdquo; and expects the stock to "generate rapid growth over the next several years." In addition, Alliance Global believes PRPO "will attract additional investor and research attention" as the company executes its business plan.</p> <p>PRPO shares touched an annual high of $10.80 on May 2, but have since surrendered roughly 70% of their value. In fact, the stock's pullback was so steep, Precipio CEO Ilan Danieli issued a letter to shareholders on Monday, June 17, to discuss "the recent pricing pressure." Danieli acknowledged that PRPO has been "under assault by the shorting interests," and reassured shareholders that the firm is not "holding back" company news. Further, the CEO said the "bottom line" is that "nothing has changed" regarding Precipio's product pipeline, and it remains "in a position to create long-term value" for PRPO shareholders.</p> <p>Despite the letter, the stock continued its retreat, and is now close to filling an early April bull gap. The security is also now trading south of its 80-day moving average -- a trendline that put a cap on rebound attempts earlier this year. At last check, PRPO is down 3.8% to trade at $3.00.</p> <p style="text-align: center;"><img style="vertical-align: middle;" title="PRPO stock chart june 20" alt="PRPO stock chart june 20" data-displaymode="Original" src="https://cdn.schaeffersresearch.com/images/default-source/schaeffers-cdn-images/2019/06/Intraday/prpo-stock-chart-june-20.jpg?sfvrsn=0" /></p> <p>Aptinyx stock, meanwhile, scored a fresh "outperform" rating and $12 price target from SVB Leerink -- representing nearly four times yesterday's close of $3.11. APTX shares have struggled since a massive <a href="https://www.schaeffersresearch.com/content/ezines/2019/01/16/goldman-sachs-earnings-win-lifts-dow-triple-digits"><strong>January bear gap</strong></a>, which stemmed from poorly received data on the company's diabetic nerve treatment. The security has subsequently stair-stepped even lower beneath its 30-day moving average, touching a record low of $2.88 on June 7. At last check, APTX is up 4.8% to trade at $3.26.</p> <p style="text-align: center;"><img style="vertical-align: middle;" title="APTX stock chart june 20" alt="APTX stock chart june 20" data-displaymode="Original" src="https://cdn.schaeffersresearch.com/images/default-source/schaeffers-cdn-images/2019/06/Intraday/aptx-stock-chart-june-20.jpg?sfvrsn=0" /></p> <p>Despite the stock's struggles in 2019, today's new analyst attention is par for the course. In fact, four of five analysts following the equity maintain "buy" or better opinions, and the consensus 12-month price target rests at a lofty $13.</p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p>The shares of <strong>Coupa Software Inc (NASDAQ:COUP)</strong> gapped nearly 10% higher on June 4, after the Business Spend Management software specialist's strong earnings report was met with a round of bullish brokerage notes. The tech stock went on to tag a record high of $129.40 on June 10, and following a brief consolidation atop its 10-day moving average, is now back near this technical milestone. A reliable bullish signal just sounded for COUP stock, too, suggesting higher highs could be on the horizon.</p> <p>In the wake of Coupa Software's first-quarter earnings reveal, volatility expectations imploded on the stock -- pointing to attractively priced short-term options premiums. Its <strong><a href="https://www.schaeffersresearch.com/content/education/2015/07/23/making-sense-of-these-3-schaeffers-indicators">Schaeffer's Volatility Index</a></strong> (SVI) is currently docked at 44%, which registers lower than 87% of similar readings in the past year. </p> <p>According to Schaeffer's Quantitative Analyst Chris Prybal, there have been three other times COUP was trading within 2% of new highs while its SVI ranks in the 20th annual percentile or below. Looking one month out after these previous three signals, the stock was higher each time, boasting an average gain of 11.3%. Another move of this magnitude would put the shares above $142 for the first time ever, based on their current perch at $127.95.</p> <p>There's an ample amount of skepticism priced into Coupa Software stock, too, which could create tailwinds on a potential unwind. Despite the onslaught of bullish notes earlier this month, there are still five "hold" ratings levied against COUP. Plus, the average 12-month price target of $117 is a discount to current trading levels.</p> <p>Meanwhile, short sellers have been busy building bearish positions on COUP. Short interest jumped 15% in the two most recent reporting periods to a record 7.11 million shares. This represents 13.3% of the equity's available float, or 4.4 times the average daily pace of trading. A capitulation from some of the weaker bearish hands could vault COUP higher in the short term.</p> <p>While COUP stock is on pace for a double-digit percentage gain in June, it's also headed for its third straight monthly win. Year-to-date, the shares have more than doubled, and a recent bounce off their previous highs in the $116-$117 region have them within striking distance of their all-time peak, up 0.8% today at $127.90.</p> <p style="text-align: center;"><img style="vertical-align: middle;" title="coup stock daily chart june 20" alt="coup stock price chart on june 20" data-displaymode="Original" src="https://cdn.schaeffersresearch.com/images/default-source/schaeffers-cdn-images/2019/06/Intraday/coup-stock-daily-chart-june-20.jpg?sfvrsn=0" /></p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p>All eyes will be on the two-day G-20 summit meeting that begins on Friday, June 28, in in Osaka, Japan. After months of speculation, trade tensions, and new tariffs, President Donald Trump and <a href="https://www.schaeffersresearch.com/content/ezines/2019/06/18/dow-nabs-353-point-win-on-china-trade-optimism"><strong>Chinese President Xi Jinping</strong></a> will meet to discuss a trade deal.&nbsp;</p> <p>But prior to the big geopolitical summit, there's plenty to keep investors occupied. There will be blue-chip earnings reports from <a href="https://www.schaeffersresearch.com/content/analysis/2019/05/08/2-athleisure-stocks-that-could-heat-up-this-summer"><strong>Nike</strong></a>&nbsp;(NKE) and Walgreens Boots Alliance (WBA), as well as chip concern Micron (MU) and shipping giant FedEx (FDX). The latest gross domestic product (GDP) estimate will also be reported, as well as data on durable goods orders.&nbsp;</p> <p>Below is a brief list of some key market events scheduled for the upcoming week. All earnings dates listed below are tentative and subject to change. Please check with each company's respective website for official reporting dates.</p> <p>On<strong> Monday, June 24</strong>, the week will kick off with the&nbsp;Dallas&nbsp;Fed&nbsp;manufacturing survey. There are no notable earnings.</p> <p><strong>Tuesday, June 25</strong>, will feature the S&amp;P CoreLogic Case-Shiller&nbsp;home price index, new home sales, consumer confidence data, and remarks from St. Louis Fed President James&nbsp;Bullard. FedEx (FDX), Micron Technology (MU), AeroVironment (AVAV), and <a href="https://www.schaeffersresearch.com/content/analysis/2019/06/18/analyst-beware-len-stock-before-earnings"><strong>Lennar</strong></a> (LEN) will step into the earnings confessional.&nbsp;</p> <p><strong></strong></p> <p><strong>Wednesday, June 26</strong>,<strong> </strong>is jam-packed with weekly crude inventories, data on<strong>&nbsp;</strong>MBA&nbsp;mortgage applications, and durable goods orders. International trade data is also on tap. Quarterly earnings reports are expected from BlackBerry (BB), <a href="https://www.schaeffersresearch.com/content/analysis/2019/05/15/2-consumer-products-stocks-that-could-shine-next-month"><strong>General Mills</strong></a> (GIS), KB Home (KBH), and PayChex (PAYX).&nbsp;</p> <p>The latest GDP data is slated for<strong>&nbsp;Thursday, June 27</strong>. There will also be weekly jobless claims, the pending home sales index, and the Fed balance sheet. On the earnings front, Nike (NKE), Walgreens Boots Alliance (WBA),&nbsp;Accenture (ACN), and Conagra Brands (CAG) will report.<strong></strong></p> <p>It's a busy close to the week on<strong> Friday, June 28</strong>, with the G-20 summit kicking off. And in addition to data on personal income and&nbsp;outlays, the Chicago purchasing managers manufacturing&nbsp;index&nbsp;(PMI), the&nbsp;Baker-Hughes rig count, and more consumer sentiment data are all due out. <a href="https://www.schaeffersresearch.com/content/news/2019/05/31/beer-stock-could-be-big-tariff-loser"><strong>Constellation Brands</strong></a> (STZ) and JinkoSolar (JKS) close out the week on the earnings front.</p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p>Cereal maker&nbsp;<strong>General Mills, Inc. (NYSE:GIS)</strong> will step into the earnings confessional n before the open next Wednesday, June 26. At last check, GIS is up 0.8% to trade at $53.79 today, and earlier nabbed a new annual high of $53.89. Ahead of the event next week, there is a <a href="https://www.schaeffersresearch.com/content/analysis/2019/05/15/2-consumer-products-stocks-that-could-shine-next-month"><strong>reliable signal</strong></a> flashing that indicates GIS' hot streak is far from over.</p> <p>Specifically, the stock's Schaeffer's Volatility Index (SVI) of 27% ranks in the 5th percentile of its annual range. This indicates short-term options are cheap, from a volatility perspective. Per data from Schaeffer's Senior Quantitative Analyst Chris Prybal, the four other times since 2008 that GIS was trading within 2% of a new 52-week high while its SVI was ranked in the bottom 20th percentile of its annual range, the equity averaged a one-month gain of 6.4%, and was positive three times.</p> <p>A move of similar magnitude would put the equity near $57.23 for the first time since January 2018. General Mills stock gapped lower in late May, but the pullback was contained by ts 100-day moving average. Since then, GIS has only turned in three negative sessions, extending its year-to-date lead 38%.&nbsp;</p> <p style="text-align: center;"><img src="https://cdn.schaeffersresearch.com/images/default-source/schaeffers-cdn-images/2019/06/Intraday/daily-stock-chart-gis.jpg?sfvrsn=2" data-displaymode="Original" alt="Daily Stock Chart GIS" title="Daily Stock Chart GIS" style="vertical-align: middle;" /></p> <p> </p> <p>Looking at the company's earnings history, the stock has only closed higher the day after earnings in four of the last eight quarters -- including a 5% pop back in December . Over the past two years, the shares have swung an average of 4.2% the day after earnings, regardless of direction. But today, option traders are pricing in an even wider swing of 6.5% for the stock, based on near-term at-the-money straddle data.</p> <div> </div> <p>Calls have reigned in the options pits in recent weeks, despite limited absolute volume. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), 2,082 calls were bought to open in the past two weeks, compared to just 270 puts. The resultant call/put volume ratio of 7.71 ranks in the 100th percentile of its annual range.</p> <p>The good news for options traders is that GIS has already shown a tendency to make bigger moves than options traders were expecting in the past year, based on its Schaeffer's Volatility Scorecard (SVS) of 86 out of a possible 100.</p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p>Car resale giant&nbsp;<strong>CarMax, Inc (NYSE:KMX)</strong> is slightly lower this afternoon, last seen down 0.6% at $83.01. Traders are most likely gearing up for the company's first-quarter earnings report, slated for release before the market opens tomorrow, June 21. Below we will take a look at how KMX has been doing on the charts, and what the options market is pricing in for the stock's post-earnings moves.</p> <p>CarMax stock has being climbing the charts since a late-March post-earnings bull gap. Year-to-date, the security has added just over 30%, and after consolidating atop the 40-day moving average and $76 mark, KMX touched a <strong><a href="https://www.schaeffersresearch.com/content/options/2019/06/17/wall-street-betting-on-upside-for-kmx-stock-with-earnings-near">record high</a></strong> of $84.99 this past Monday, June 17.</p> <p style="text-align: center;"><img src="https://cdn.schaeffersresearch.com/images/default-source/schaeffers-cdn-images/2019/06/Intraday/revised-daily-kmx-since-jan-with-40ma.jpg?sfvrsn=0" data-displaymode="Original" alt="Revised Daily KMX Since Jan with 40MA" title="Revised Daily KMX Since Jan with 40MA" style="vertical-align: middle;" /></p> <p>Digging into CarMax's&nbsp;earnings history, the stock has closed higher the day after earnings in six of the last eight quarters -- including a 9.6% surge in March, as well as&nbsp; a 12.9% gain this time last year. Over the past two years, the shares have swung an average of 5.6% the day after earnings, regardless of direction. This time around, the options market is pricing in a larger-than-usual 8.7% swing for Friday's trading.&nbsp;</p> <p>Looking toward analyst sentiment, CarMax stock has scored several bull notes ahead of earnings. Just this week, KMX saw price-target hikes from both Credit Suisse and RBC -- to $90 and $92, respectively. Likewise, the security hosts 10 "buy" or better ratings, just one "hold," and zero "sells." However, the consensus 12-month price target of $85.46 is just a hair's breadth from current levels. Should the company once again report stronger-than-expected earnings, there's room for additional price-target increases.</p> A strong earnings showing could also shake loose some shorts. Short interest surged more than 30% in the most recent reporting period, and now accounts for nearly 13% of KMX's total available float. At the stock's average pace of trading, it would take more than 12 sessions to buy back these bearish bets -- ample fuel for a potential short squeeze to drive the shares to new heights.
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p>Canada-based marijuana concern <strong>Canopy Growth Corp (NYSE:CGC)</strong> is trading higher today, up 1.3% at $43.31, right ahead of the firm's fiscal fourth-quarter earnings release after the close today. The weed stock is higher after shareholders approved the company's acquisition of Acreage Holdings yesterday evening. </p> <p>Canopy has only one other earnings report to its name, and the next-day return for the stock was 3.1%. The options market is pricing in a much bigger swing of 11.2% for tomorrow's trading, and speculators appear to be positioning for another post-earnings upside move. </p> <p>So far today, 18,000 calls have crossed the tape, two times the average intraday amount. Most of the activity is surrounding the June 45 and weekly 6/28 50-strike calls. Those buying to open these calls expect major upside for the equity by the time these contracts expire.</p> <p>CGC has seen an impressive run on the charts lately, too. The stock is eyeing its fourth consecutive win, and vying for its first close atop its 30-day moving average -- which has served as a recent ceiling -- for the first time in over a month. The stock's $44 region, however, is still serving as pervasive pressure for the stock, squelching CGC's last two rallies. Despite this, the equity has still managed a 61.1% year-to-date gain.&nbsp;</p> <p style="text-align: center;"><img src="https://cdn.schaeffersresearch.com/images/default-source/schaeffers-cdn-images/2019/06/Intraday/cgc-june-20.jpg?sfvrsn=0" data-displaymode="Original" alt="CGC June 20" title="CGC June 20" style="vertical-align: middle;" /></p> <p>Should tonight's earnings results prove favorable, upgrades from the brokerage bunch could be in the cards. While the majority of the 14 analysts consider Canopy a "buy" or better, four have slapped the pot stock with a tepid "hold." The consensus 12-month target price of $56.19, however, is at a roughly 30% premium to the stock's current perch.&nbsp;</p> <p>An <strong><a href="https://www.schaeffersresearch.com/education/expectational-analysis/sentiment-analysis/short-interest">unwinding of shorts</a></strong> could push the stock higher, too. Short interest shot up 12.6% in the last two reporting periods. The record 30.71 million shares sold short represents a whopping 15% of the stock's available float. At CGC's average pace of trading, it would take over a week to cover all these pessimistic positions.&nbsp;</p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 
<p><strong>Hershey Co (NYSE:HSY)</strong> shares are trading down 0.5% this morning at $137.15, after Piper Jaffray downgraded the stock to "underweight" from "neutral" and set a $125 price target, saying the company's valuation is too high compared to its peers. This comes after HSY hit an all-time high of $139.34 earlier this month, with the equity sporting a nearly 29% year-to-date lead. In fact, this would only be just the third time the shares closed below the 10-day moving average since March. </p> <p>This marks the first rating that's worse than a "hold" on the security, which is what 10 of the 11 covering brokerages had on the shares coming into today. There was also one lone firm with a "strong buy" recommendation. What's more, the average 12-month price target is down at $122.93. </p> <p>Meanwhile, near-term options traders are unusually call-skewed on Hershey, according to the Schaeffer's put/call open interest ratio (SOIR) of 0.71. This reading ranks in the 5th annual percentile, showing that call open interest outweighs put open interest among contracts expiring within three months by a wider-than-usual margin at the moment. And this comes at a time when HSY options have been oddly popular overall, with open interest right now of 61,442 contracts ranking as a 52-week high. </p> <p>&nbsp;</p>
Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

<p><strong>Tesla Inc (NASDAQ:TSLA)</strong> stock is down 1.6% this morning to trade at $226.43, in reaction to a scathing bear note from Goldman Sachs. The brokerage firm slashed its TSLA price target to $158 from $200 -- a 30% discount to last night's close -- saying, "a downward path for shares will resume as it becomes more clear that sustainable demand for the company&rsquo;s current products are below expectations." Goldman maintained its "sell" rating on Tesla stock.</p> <p>Analysts are already skeptical of TSLA, with 14 of 22 covering brokerages maintaining a "hold" or "strong sell" rating on the stock. However, the average 12-month price target sits all the way up at $285.41, a 26% premium to current levels, and territory Tesla shares haven't traded in since early April.</p> <p><strong><a href="https://www.schaeffersresearch.com/content/options/2019/06/10/beyond-meat-lands-on-most-active-options-list">Options traders</a></strong>, on the other hand, are betting on a big bounce for Tesla. The June 250 call has seen the biggest increase in open interest over the past 10 days, with more than 30,000 contracts added. Data from the major options exchanges confirms significant buy-to-open activity here, meaning speculators are anticipating a move above $250 by July options expiration.</p> <p>Some of the activity at this out-of-the-money call could be at the hands of shorts guarding their bearish bets against any upside risk. Short interest on TSLA surged 16.1% in the most recent reporting period to 43.63 million shares, representing roughly one-third of the equity's available float.</p> <p>On the charts, short sellers have certainly been in the driver's seat, with Tesla stock down almost 33% year-to-date. And while the shares have come off their June 3 three-year low of $176.99, they are running into trouble at their 50-day moving average -- a trendline that's guided TSLA lower since a mid-January bear gap.</p> <p>&nbsp;</p>
Read Full Article

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview